Phase I safety study of 0.5% PRO 2000 vaginal Gel among HIV un-infected women in Pune, India
2006

Safety Study of PRO 2000 Gel in Women

Sample size: 42 publication Evidence: moderate

Author Information

Author(s): Smita Joshi, Soma Dutta, Beverly Bell, Albert Profy, JoAnn Kuruc, Fang Gai, Missy Cianciola, Lydia Soto-Torres, Anjali Panchanadikar, Arun Risbud, Sanjay Mehendale, Steven J Reynolds

Primary Institution: National AIDS Research Institute, India

Hypothesis

Is 0.5% PRO 2000 Gel safe for use among HIV un-infected women?

Conclusion

0.5% PRO 2000 Gel appeared to be safe when used twice-daily by sexually active HIV-uninfected women from Pune, India.

Supporting Evidence

  • 57% of participants experienced at least one adverse event.
  • No serious adverse events were reported.
  • Genitourinary discomfort was more common in the high-risk cohort.

Takeaway

The study tested a gel to see if it was safe for women who don't have HIV. Most women felt fine using it.

Methodology

Forty-two eligible volunteers used 0.5% PRO 2000 Gel twice daily for 14 days.

Potential Biases

Participants may have reported symptoms due to heightened monitoring.

Limitations

The study lacked a placebo control group, making it difficult to determine if adverse events were related to the gel.

Participant Demographics

All participants were married, literate, aged 21-42, with 30 low-risk and 12 high-risk women.

Statistical Information

P-Value

0.03

Confidence Interval

95% CI 41%–72%

Statistical Significance

p = 0.03

Digital Object Identifier (DOI)

10.1186/1742-6405-3-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication